$678 Updated safety and efficacy of toripalimab combined with cetuximab in platinum-refractory recurrent or metastatic head and neck squamous cell carcinoma (R/M-HNSCC): a phase Ib/II clinical trial$

678 Updated safety and efficacy of toripalimab combined with cetuximab in platinum-refractory recurrent or metastatic head and neck squamous cell carcinoma (R/M-HNSCC): a phase Ib/II clinical trial

Bibliographic Details
Main Authors:	Wei Wang, Mo Wang, Zhiming Li, Xiaoming Huang, Siyang Wang, Chuan Jin, Hao Jiang, Xudong Wang, Ye Guo, Zhendong Li, Desheng Hu, Guochun Cao, Song Qu, Youhua Zhu, Meiyu Fang, Wantao Chen, Chuanzheng Sun, Jingfeng Zong, Jinguan Lin, Minghua Ge, Xianming Luo, Shuanghui Wei, Yuteng Shen
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

678 Updated safety and efficacy of toripalimab combined with cetuximab in platinum-refractory recurrent or metastatic head and neck squamous cell carcinoma (R/M-HNSCC): a phase Ib/II clinical trial

Similar Items